Literature DB >> 7543311

Potentiation of warfarin by interferon.

Y Adachi1, Y Yokoyama, T Nanno, T Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7543311      PMCID： PMC2550360          DOI： 10.1136/bmj.311.7000.292a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Depression of drug metabolizing activity in the human liver by interferon-alpha.

Authors:  H Okuno; Y Kitao; M Takasu; H Kano; K Kunieda; T Seki; Y Shiozaki; Y Sameshima
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The effect of warfarin on mortality and reinfarction after myocardial infarction.

Authors:  P Smith; H Arnesen; I Holme
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

3.  Inhibition of theophylline metabolism by interferon.

Authors:  S J Williams; J A Baird-Lambert; G C Farrell
Journal:  Lancet       Date:  1987-10-24       Impact factor: 79.321

4.  Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.

Authors:  K W Renton; G Singh; N Stebbing
Journal:  Biochem Pharmacol       Date:  1984-12-01       Impact factor: 5.858

5.  Depression of drug-metabolizing activity in the human liver by interferon-beta.

Authors:  H Okuno; M Takasu; H Kano; T Seki; Y Shiozaki; K Inoue
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425
  5 in total
  3 in total

1.  Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity.

Authors:  Karin Hellman; Ewa Roos; Anna Osterlund; Anneli Wahlberg; Lars L Gustafsson; Leif Bertilsson; Sten Fredrikson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

2.  Immunological response as a source to variability in drug metabolism and transport.

Authors:  Hege Christensen; Monica Hermann
Journal:  Front Pharmacol       Date:  2012-02-10       Impact factor: 5.810

3.  Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report.

Authors:  Andrew S Tsiattalos; Anita Patel
Journal:  J Med Case Rep       Date:  2014-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.